Australia markets close in 48 minutes

Genenta Science S.p.A. (GNTA)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
3.7000+0.2800 (+8.19%)
At close: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 67.40M
Enterprise value 47.22M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)3.06
Enterprise value/revenue N/A
Enterprise value/EBITDA -4.04

Trading information

Stock price history

Beta (5Y monthly) 0.72
52-week change 3-37.82%
S&P500 52-week change 325.59%
52-week high 36.8100
52-week low 32.2000
50-day moving average 33.6565
200-day moving average 34.7131

Share statistics

Avg vol (3-month) 35.5k
Avg vol (10-day) 34.31k
Shares outstanding 518.22M
Implied shares outstanding 618.22M
Float 811.14M
% held by insiders 138.84%
% held by institutions 18.05%
Shares short (15 Apr 2024) 43.9k
Short ratio (15 Apr 2024) 40.55
Short % of float (15 Apr 2024) 40.03%
Short % of shares outstanding (15 Apr 2024) 40.02%
Shares short (prior month 15 Mar 2024) 43.25k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in EUR.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-26.29%
Return on equity (ttm)-45.16%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -11.69M
Net income avi to common (ttm)-11.65M
Diluted EPS (ttm)-0.6900
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)18.78M
Total cash per share (mrq)1.03
Total debt (mrq)27.19k
Total debt/equity (mrq)0.13%
Current ratio (mrq)12.25
Book value per share (mrq)1.12

Cash flow statement

Operating cash flow (ttm)-11.21M
Levered free cash flow (ttm)-7.58M